Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Asker Healthcare Group AB ( (SE:ASKER) ) has provided an announcement.
Asker Healthcare Group AB reported a strong third quarter in 2025, with a 25% increase in adjusted EBITA, driven by both organic growth and strategic acquisitions. The company has expanded its footprint in the European healthcare market, including a significant entry into the French market through the acquisition of Finmed Group, enhancing its product offerings and market position.
The most recent analyst rating on (SE:ASKER) stock is a Hold with a SEK90.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group AB operates in the healthcare industry, focusing on providing medical devices, equipment, and related services to hospitals and healthcare institutions. The company is actively expanding its market presence through strategic acquisitions, particularly in Europe.
Average Trading Volume: 1,148,729
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK34.14B
For a thorough assessment of ASKER stock, go to TipRanks’ Stock Analysis page.